1 |
dpavlin |
1.1 |
<table width="100%" border="0" cellspacing="0" cellpadding="0"> |
2 |
|
|
<tr> |
3 |
|
|
<td height="114"> |
4 |
|
|
<table border="1" cellspacing="0" cellpadding="3" align="center" bordercolor="#283880"> |
5 |
|
|
<tr> |
6 |
|
|
<td><img src="p/pic_kastel.gif" width="300" height="131"></td> |
7 |
|
|
</tr> |
8 |
|
|
</table> |
9 |
|
|
</td> |
10 |
|
|
</tr> |
11 |
|
|
<tr> |
12 |
|
|
<td height="405"> |
13 |
|
|
<p align=center> </p> |
14 |
|
|
<ul> |
15 |
|
|
|
16 |
|
|
|
17 |
|
|
|
18 |
|
|
<li><font face="Arial, Helvetica, sans-serif" color="#000080"><small><strong>1921</strong> |
19 |
|
|
Kastel d.d. is founded</small></font> |
20 |
|
|
<li><font face="Arial, Helvetica, sans-serif" color="#000080"><small><strong>1928</strong> |
21 |
|
|
Kastel d.d. moves to Zagreb</small></font> |
22 |
|
|
<li><font face="Arial, Helvetica, sans-serif"><small><font |
23 |
|
|
color=#000080><strong>1936</strong> the company becomes one of the first |
24 |
|
|
global sulfonamide producers</font></small> |
25 |
|
|
</font> |
26 |
|
|
<li><font face="Arial, Helvetica, sans-serif"><small><font |
27 |
|
|
color=#000080><strong>1940</strong> Plibah-Bannat Institute for production |
28 |
|
|
of biological and chemical medicines</font></small> |
29 |
|
|
</font> |
30 |
|
|
<li><font face="Arial, Helvetica, sans-serif" color="#000080"><small><strong>1941</strong> |
31 |
|
|
Plibah become PLIVA-State Institute for Production |
32 |
|
|
of Medicines & Vaccines</small></font> |
33 |
|
|
<li><font face="Arial, Helvetica, sans-serif" color="#000080"><small><strong>1952</strong> |
34 |
|
|
PLIVA Research Institute is founded</small></font> |
35 |
|
|
<li><font face="Arial, Helvetica, sans-serif"><small><font |
36 |
|
|
color=#000080><strong>1953</strong> the first quantities of Vitamin C |
37 |
|
|
are manufactured using in-house technology</font></small> |
38 |
|
|
</font> |
39 |
|
|
<li><font face="Arial, Helvetica, sans-serif"><small><font |
40 |
|
|
color=#000080><strong>1959</strong> production of Vitamin B and oxytetracycline |
41 |
|
|
is begun</font></small> </font> |
42 |
|
|
<li><font face="Arial, Helvetica, sans-serif"><small><font |
43 |
|
|
color=#000080><strong>1971</strong> methacycline is patented</font></small> |
44 |
|
|
</font> |
45 |
|
|
<li><font face="Arial, Helvetica, sans-serif" color="#000080"><small><strong>1980</strong> |
46 |
|
|
PLIVAs original macrolide antibiotic-azithromycin |
47 |
|
|
is patented and protected</small></font> |
48 |
|
|
<li><font face="Arial, Helvetica, sans-serif" color="#000080"><small><strong>1986</strong> |
49 |
|
|
PLIVA signs a licensing agreement with US company |
50 |
|
|
Pfizer, granting Pfizer an exclusive right for |
51 |
|
|
the sale of azithromycin in the USA and western |
52 |
|
|
Europe</small></font> |
53 |
|
|
<li><font face="Arial, Helvetica, sans-serif" color="#000080"><small><strong>1988</strong> |
54 |
|
|
PLIVA launched azithromycin under the name of |
55 |
|
|
Sumamed</small></font> |
56 |
|
|
<li><font face="Arial, Helvetica, sans-serif"><small><font |
57 |
|
|
color=#000080><strong>1991</strong> Pfizer launched azithromycin under |
58 |
|
|
the name of Zithromax</font></small> </font> |
59 |
|
|
<li><font face="Arial, Helvetica, sans-serif" color="#000080"><small><b>1991</b> |
60 |
|
|
Croatia becomes an independent state and <b>PLIVA</b> |
61 |
|
|
begins its privatization process</small></font> |
62 |
|
|
<li><font face="Arial, Helvetica, sans-serif" color="#000080"><b><small>1993 |
63 |
|
|
PLIVA</small></b><small> becomes a joint stock |
64 |
|
|
company</small></font> |
65 |
|
|
<li><font face="Arial, Helvetica, sans-serif" color="#000080"><small><b>1996 |
66 |
|
|
</b>The listing of <b>PLIVA</b>s shares on |
67 |
|
|
the London Stock Exchange marks the 75th anniversary |
68 |
|
|
of <b>PLIVA</b></small></font> |
69 |
|
|
<li><font face="Arial, Helvetica, sans-serif" color="#000080"><small><b>1997</b> |
70 |
|
|
Acquisition of<b> </b>majority stake of <b>Polfa |
71 |
|
|
- Krakow </b>(presently - <b>PLIVA Krakow</b>)</small></font> |
72 |
|
|
<li><font face="Arial, Helvetica, sans-serif" color="#000080"><small><b>1998 </b> new azithromycin production facility was open</small></font> |
73 |
|
|
<li><font face="Arial, Helvetica, sans-serif" color="#000080"><small><b>1998 |
74 |
|
|
</b>Acquisition of Slovak Yeast Producer,<b> |
75 |
|
|
Fermenta </b></small></font> |
76 |
|
|
|
77 |
|
|
<li><font face="Arial, Helvetica, sans-serif" color="#000080"><b><small>1999 |
78 |
|
|
</small></b><small>Acquisition of FARMACOM, |
79 |
|
|
of MIXIS GENETICS Ltd., and of LACHEMA (presently |
80 |
|
|
- <b>PLIVA LACHEMA</b>)</small></font> </li> |
81 |
|
|
<li><font face="Arial, Helvetica, sans-serif" color="#000080"><b><small>2000 |
82 |
|
|
</small></b><small>Acquisition of Dominion |
83 |
|
|
</small></font> </li> |
84 |
|
|
</ul> |
85 |
|
|
</td> |
86 |
|
|
</tr> |
87 |
|
|
<tr> |
88 |
|
|
<td> |
89 |
|
|
<table border="1" cellspacing="0" cellpadding="3" align="center" bordercolor="#283880"> |
90 |
|
|
<tr> |
91 |
|
|
<td><img src="p/hist_savskimarof.gif" width="200" height="200"></td> |
92 |
|
|
</tr> |
93 |
|
|
</table> |
94 |
|
|
</td> |
95 |
|
|
</tr> |
96 |
|
|
</table> |